Mozobil Interactions
No drug interactions were found for Mozobil (plerixafor). However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Mozobil (plerixafor) is in the following drug classes: hematopoietic stem cell mobilizer, other immunostimulants. Mozobil (plerixafor) is used to treat the following conditions: Hematopoietic Stem Cell Mobilization, Multiple Myeloma, Non-Hodgkin's Lymphoma.
Mozobil disease interactions
There are 3 disease interactions with Mozobil (plerixafor) which include:
More about Mozobil (plerixafor)
- Mozobil consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: hematopoietic stem cell mobilizer
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.